National Health Investors (NYSE:NHI) Downgraded by Bank of America to Underperform

National Health Investors (NYSE:NHI - Get Free Report) was downgraded by investment analysts at Bank of America from a "buy" rating to an "underperform" rating in a report issued on Friday, FinViz reports. They currently have a $67.00 price objective on the real estate investment trust's stock, down from their previous price objective of $86.00. Bank of America's price target would suggest a potential upside of 3.60% from the stock's current price.

Other research analysts have also recently issued research reports about the company. BMO Capital Markets reiterated an "outperform" rating on shares of National Health Investors in a research note on Wednesday, September 23rd. Weiss Ratings cut National Health Investors from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Friday, September 25th. Zacks Research upgraded National Health Investors from a "strong sell" rating to a "hold" rating in a report on Tuesday, September 29th. National Bank Financial set a $79.00 price target on National Health Investors in a research report on Wednesday, September 9th. Finally, Truist Financial dropped their price target on shares of National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a research note on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $79.44.

National Health Investors Trading Down 2.0%

NYSE:NHI opened at $64.67 on Friday. The firm has a market capitalization of $3.18 billion, a P/E ratio of 4.54, a PEG ratio of 4.21 and a beta of 0.51. The company has a debt-to-equity ratio of 0.50, a current ratio of 13.59 and a quick ratio of 6.78. National Health Investors has a one year low of $63.51 and a one year high of $91.38. The company's 50-day simple moving average is $67.48 and its 200 day simple moving average is $75.93.

National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, beating analysts' consensus estimates of $1.18 by $10.29. National Health Investors had a net margin of 152.82% and a return on equity of 41.41%. The business had revenue of $113.48 million during the quarter, compared to the consensus estimate of $68.53 million. As a group, analysts forecast that National Health Investors will post 4.76 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of NHI. BlackRock Inc. bought a new position in shares of National Health Investors during the second quarter valued at $665,997,000. Bank of New York Mellon Corp bought a new stake in National Health Investors in the 2nd quarter worth about $122,509,000. Bank of America Corp DE purchased a new position in National Health Investors in the 2nd quarter worth about $77,738,000. Dimensional Fund Advisors LP raised its position in National Health Investors by 2.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust's stock worth $55,493,000 after buying an additional 18,164 shares during the last quarter. Finally, Legal & General Group Plc bought a new position in National Health Investors during the 2nd quarter valued at about $21,745,000. Hedge funds and other institutional investors own 62.51% of the company's stock.

Top National Health Investors Stories

Here are a few of the latest stories about NHI:

• Positive Sentiment: Huntington initiated coverage with a “Strong Buy” rating and forecasts EPS rising from $4.76 in 2026 to $5.00 in 2027 and $5.27 in 2028. Its 2026 estimate is modestly above the cited $4.69 consensus, while the longer-term projections point to expected earnings growth. Huntington rating
• Neutral Sentiment: NHI’s Q3 FFO of $1.12 per share matched FactSet expectations, indicating results were in line rather than a surprise catalyst. Q3 FFO results
• Neutral Sentiment: A Zacks article compares NHI with RLJ Lodging as a value investment but the provided excerpt gives no conclusion on which stock is more attractive. Zacks value comparison

National Health Investors Company Profile

National Health Investors, Inc. NYSE: NHI is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI's portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.